Reduction of the total IgE Level by omalizumab in children and adolescents.
Slavin
Raymond G
RG
Jimenez
Pablo
P
D000293:Adolescent; D018927:Anti-Asthmatic Agents / Q000008:administration & dosage / Q000627:therapeutic use; D000888:Antibodies, Anti-Idiotypic; D000911:Antibodies, Monoclonal / Q000008:administration & dosage / Q000276:immunology / Q000627:therapeutic use*; D061067:Antibodies, Monoclonal, Humanized; D001249:Asthma / Q000097:blood* / Q000188:drug therapy*; D002648:Child; D002986:Clinical Trials as Topic; D016903:Drug Monitoring; D006801:Humans; D007073:Immunoglobulin E / Q000097:blood* / Q000276:immunology; D000069444:Omalizumab
D018927:Anti-Asthmatic Agents; D000888:Antibodies, Anti-Idiotypic; D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D000069444:Omalizumab; D007073:Immunoglobulin E